Skip to main content
S. 889 117th Congress Senate

Prescription Drug Monitoring Act of 2021

Official title: A bill to require the use of prescription drug monitoring programs.

Introduced: March 22, 2021 Introduced by: Amy Klobuchar Democratic · Minnesota See on congress.gov
Health Criminal justice information and recordsDrug trafficking and controlled substancesHealth information and medical recordsHealth personnel
More subjectsShow fewer subjects
Intergovernmental relationsLicensing and registrationsMedical ethicsPrescription drugsState and local government operations
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 22, 2021
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Mar 22, 2021
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action March 22, 2021

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Plain-English summary Congressional Research Service

Prescription Drug Monitoring Act of 2021

This bill imposes, as a condition on certain federal funding for the Prescription Drug Monitoring Program (PDMP), additional notification and reporting requirements concerning prescriptions for potentially addictive drugs.

States or territories that receive this funding must require

  • prescribers to consult the PDMP before starting treatment with such drugs, and
  • dispensers to report within 24 hours to the PDMP each time they fill a prescription for such drugs.

In addition, the state agency administering a PDMP must analyze reported data for patterns of prescription drug misuse or abuse and provide certain information to prescribers, law enforcement, the public, and other states and territories.

 Related & companion bills 3
  • HR 2344 Identical bill Prescription Drug Monitoring Act of 2021
  • HR 4341 CARA 3.0 Act of 2021
  • S 987 CARA 3.0 Act of 2021
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 1
All 1 Independent 1
I
King, Angus S., Jr.
Maine · Mar 22, 2021
Cite this page click to expand
APA
U.S. Congress. (2026). S. 889: Prescription Drug Monitoring Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-S-889/
MLA
"S. 889: Prescription Drug Monitoring Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-889/.
Bluebook (legal)
S. 889, 117th Cong. (2026), https://openamerica.io/bill/117-S-889/.
Markdown link
[S. 889: Prescription Drug Monitoring Act of 2021](https://openamerica.io/bill/117-S-889/)
Report a problem